Press release
Diabetic Macular Edema Pipeline Drugs and Companies Insight Report (2022): Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments
Diabetic Macular Edema Overview
Diabetic Macular Edema (DME) is an accumulation of fluid in the macula part of the retina that controls most detailed vision abilities-due to leaking blood vessels. Diabetic Macular Edema (DME) is a potential complication of DR. Diabetic retinopathy (DR) is a complication of diabetes that may be unnoticeable in its early stages, but which can lead to vision impairment and blindness. It is caused by disruption of the blood-retinal barrier due to long-term hyperglycaemia (high blood glucose), leading to retinal thickening around the fovea. DME currently affects more than 28 million people with diabetes.
"Diabetic Macular Edema Pipeline Insight, 2022" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Diabetic Macular Edema Market.
The Diabetic Macular Edema Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Diabetic Macular Edema Pipeline Report: https://www.delveinsight.com/report-store/diabetic-macular-edema-dme-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Companies across the globe are diligently working toward developing novel Diabetic Macular Edema treatment therapies with a considerable amount of success over the years. Diabetic Macular Edema Key players such as - Eluminex BioSciences, Ocugen, Innovent biologics, Curacle, GlaxoSmithKline, Ocuphire Pharma, Unity Biotechnology, Allgenesis Biotherapeutics Inc., Mylan, Kodiak Sciences, and others, are developing therapies for the Diabetic Macular Edema treatment
Diabetic Macular Edema Emerging therapies such as - EB-102, OCU200, IBI324, CU06-1004, GSK-2798745, APX3330, UBX1325, AG-73305, MYL-1701P, KSI-301, and others are expected to have a significant impact on the Diabetic Macular Edema market in the coming years.
In September 2020, Kodiak Sciences initiated a Phase III, prospective, randomized, double-masked, two-arm, multi-center non-inferiority study evaluating the efficacy and safety of repeated intravitreal dosing of KSI-301 5 mg in participants with treatment-naïve DME.
Diabetic Macular Edema Pipeline Therapeutics Assessment
Diabetic Macular Edema Assessment by Product Type
Diabetic Macular Edema By Stage and Product Type
Diabetic Macular Edema Assessment by Route of Administration
Diabetic Macular Edema By Stage and Route of Administration
Diabetic Macular Edema Assessment by Molecule Type
Diabetic Macular Edema by Stage and Molecule Type
DelveInsight's Diabetic Macular Edema Report covers around products under different phases of clinical development like
Late-stage products (Phase III)
Mid-stage products (Phase II)
Early-stage product (Phase I)
Pre-clinical and Discovery stage candidates
Discontinued & Inactive candidates
Route of Administration
Emerging Diabetic Macular Edema Drugs Under Different Phases of Clinical Development Include:
EB-102: Eluminex BioSciences
OCU200: Ocugen
IBI324: Innovent biologics
CU06-1004: Curacle
GSK-2798745: GlaxoSmithKline
APX3330: Ocuphire Pharma
UBX1325: Unity Biotechnology
AG-73305: Allgenesis Biotherapeutics Inc.
MYL-1701P: Mylan
KSI-301: Kodiak Sciences
Get a Free Sample PDF Report to know more about Diabetic Macular Edema Pipeline Assessment- https://www.delveinsight.com/sample-request/diabetic-macular-edema-dme-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Diabetic Macular Edema Pipeline Analysis:
The Diabetic Macular Edema pipeline report provides insights into
The report provides detailed insights about companies that are developing therapies for the Diabetic Macular Edema treatment with aggregate therapies developed by each company for the same.
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Diabetic Macular Edema Treatment.
Diabetic Macular Edema key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
Diabetic Macular Edema Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Diabetic Macular Edema market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Further Diabetic Macular Edema product details are provided in the report. Download the Diabetic Macular Edema pipeline report to learn more about the emerging Diabetic Macular Edema therapies at:
https://www.delveinsight.com/sample-request/diabetic-macular-edema-dme-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Diabetic Macular Edema Pipeline Market Drivers
Growing Prevalence of diabetes
Development of novel therapies
Investment in Research and Development activities
Diabetic Macular Edema Pipeline Market Barriers
High medical cost
Lack of approved therapies
Scope of Diabetic Macular Edema Pipeline Drug Insight
Coverage: Global
Key Diabetic Macular Edema Companies: Eluminex BioSciences, Ocugen, Innovent biologics, Curacle, GlaxoSmithKline, Ocuphire Pharma, Unity Biotechnology, Allgenesis Biotherapeutics Inc., Mylan, Kodiak Sciences, and others
Key Diabetic Macular Edema Therapies: EB-102, OCU200, IBI324, CU06-1004, GSK-2798745, APX3330, UBX1325, AG-73305, MYL-1701P, KSI-301, and others
Diabetic Macular Edema Therapeutic Assessment: Diabetic Macular Edema current marketed and Diabetic Macular Edema emerging therapies
Diabetic Macular Edema Market Dynamics: Diabetic Macular Edema market drivers and Diabetic Macular Edema market barriers
Request for Sample PDF Report for Diabetic Macular Edema Pipeline Assessment and clinical trials- https://www.delveinsight.com/sample-request/diabetic-macular-edema-dme-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1
Diabetic Macular Edema Report Introduction
2
Diabetic Macular Edema Executive Summary
3
Diabetic Macular Edema Overview
4
Diabetic Macular Edema- Analytical Perspective In-depth Commercial Assessment
5
Diabetic Macular Edema Pipeline Therapeutics
6
Diabetic Macular Edema Late Stage Products (Phase II/III)
7
Diabetic Macular Edema Mid Stage Products (Phase II)
8
Diabetic Macular Edema Early Stage Products (Phase I)
9
Diabetic Macular Edema Preclinical Stage Products
10
Diabetic Macular Edema Therapeutics Assessment
11
Diabetic Macular Edema Inactive Products
12
Company-University Collaborations (Licensing/Partnering) Analysis
13
Diabetic Macular Edema Key Companies
14
Diabetic Macular Edema Key Products
15
Diabetic Macular Edema Unmet Needs
16
Diabetic Macular Edema Market Drivers and Barriers
17
Diabetic Macular Edema Future Perspectives and Conclusion
18
Diabetic Macular Edema Analyst Views
19
Appendix
20
About DelveInsight
Download Sample PDF Report to know more about Diabetic Macular Edema drugs and therapies- https://www.delveinsight.com/sample-request/diabetic-macular-edema-dme-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Latest Reports:
Ventricular Assist Devices Market https://www.delveinsight.com/report-store/ventricular-assist-devices-vad-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"DelveInsight's 'Ventricular Assist Devices (VAD) Market Insight, Competitive Landscape and Market Forecast - 2027' report delivers an in-depth understanding of Ventricular Assist Devices and the historical and forecasted Ventricular Assist Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Vein Illumination Devices Market https://www.delveinsight.com/report-store/vein-illumination-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Vein Illumination Devices - Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Basal Cell Carcinoma (Basal Cell Epithelioma) Market
https://www.delveinsight.com/report-store/basal-cell-carcinoma-basal-cell-epithelioma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Basal Cell Carcinoma (Basal Cell Epithelioma) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Basal Cell Carcinoma (Basal Cell Epithelioma), historical and forecasted epidemiology as well as the Basal Cell Carcinoma (Basal Cell Epithelioma) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Contact Us:
Gaurav Bora
gbora@delveinsight.com
+1(919)321-6187
www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetic Macular Edema Pipeline Drugs and Companies Insight Report (2022): Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments here
News-ID: 2805132 • Views: …
More Releases from DelveInsight Business Research
Autotransfusion Systems Market is Expected to Reach USD 816.35 million by 2032 | …
The global Autotransfusion Systems Market is witnessing steady growth as healthcare systems worldwide continue to prioritize patient safety, blood conservation, and advanced surgical efficiency. According to DelveInsight's latest report, the market was valued at USD 512.82 million in 2024 and is projected to reach USD 816.35 million by 2032, expanding at a CAGR of 6.04% during the forecast period (2025-2032).
Autotransfusion systems are gaining traction across hospitals and surgical centers due…
Global Automatic Mechanical Cardiopulmonary Resuscitation (CPR) Devices Market t …
According to DelveInsight's latest report, "Automatic Mechanical Cardiopulmonary Resuscitation (CPR) Devices Market by Product Type, Power Source, End-User, and Geography," the global market is projected to grow at a steady compound annual growth rate (CAGR) of 5.36% during the forecast period from 2025 to 2032. The market, valued at USD 150.65 million in 2024, is anticipated to reach USD 227.88 million by 2032, driven by the increasing prevalence of cardiovascular…
Global Airway Management Devices Market is Expected to Reach USD 2.29 billion by …
The global Airway Management Devices Market is on a robust growth trajectory, projected to expand from USD 1.60 billion in 2023 to USD 2.29 billion by 2032, growing at a steady CAGR of 6.21% during the forecast period (2025-2032). The increasing prevalence of respiratory disorders such as asthma, COPD, and airway obstructions, along with a rise in surgical procedures and worsening air pollution, are among the primary factors fueling market…
Cartilage Diseases Market Analysis 2032 - Competitive Landscape, Clinical Trials …
Cartilage Diseases Market Analysis 2032 - Competitive Landscape, Clinical Trials, Market Share, Therapies, Prevalence, and Key Players by DelveInsight
Cartilage Diseases companies are Regeneron, TissueGene, Vericel Corporation, Genzyme Corporation, Eli Lilly and Company, Incyte Corporation, Astellas Pharma, Pfizer, Sanofi, among others. Promising Cartilage Diseases therapies are Olumiant (Baricitinib), Celebrex (Celecoxib), Motrin (Ibuprofen), Kevzara (Sarilumab), and others.
DelveInsight's "Cartilage Diseases Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of…
More Releases for Diabetic
Rising Diabetic Population Fuels Growth In The Diabetic Footwear Market Emerges …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Diabetic Footwear Market Through 2025?
The size of the market for diabetic footwear has seen significant expansion in the past few years. From $8.45 billion in 2024, it is set to increase to $9.2 billion in 2025, exhibiting a compound annual growth…
Diabetic Socks Market Dynamics Shaped by Rising Diabetic Population - Persistenc …
The diabetic socks market is gaining significant traction worldwide, driven by the rising prevalence of diabetes and related complications such as diabetic neuropathy and foot ulcers. Designed specifically to cater to the needs of diabetic patients, these socks play a crucial role in foot protection by preventing blistering, reducing moisture accumulation, and providing cushioning to minimize the risk of ulcers. This article delves deeply into the diabetic socks market, exploring…
Diabetic Food Market
Future Market Insights (FMI) delivers key insights on the global diabetic food market in its latest report titled “Diabetic Food Market: Global Industry Analysis and Opportunity Assessment, 2014 – 2020”. The global diabetic food market is expected to amplify at a CAGR of 5.9% during the forecast period in terms of value due to various factors, regarding which FMI offers fundamental insights in detail in this report.
On the basis of…
Diabetic Food Market
Diabetes refers to a metabolic disease which leads to high blood sugar levels. The main cause behind diabetes is the insufficient insulin or no response in the body cells where the insulin is produced. Diabetic foods are dietary products rich in carbohydrates and sugar content. They help in controlling rising blood glucose. Diabetic food is low in calorie sweeteners and diet beverages. These products are consumed by diabetic patients and…
Demand for Diabetic Socks Due to Rising Prevalence of Diabetic Neuropathy Expect …
According to the latest market report published by Persistence Market Research titled ‘Diabetic Socks Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025,’ the global diabetic socks market is expected to expand at a CAGR of approximately 4.8% during the forecast period 2017-2025.
To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/19282
Global Diabetic Socks Market: Factors Impacting the Market
The primary factors driving the growth of the global diabetic socks market are increasing…
Diabetic Food Market -
In recent times, diabetes has emerged as one of the most challenging health conditions across the world. According to the WHO, a total of 415 million cases of diabetes were reported globally in 2015. The count is rising at an alarming rate and is expected to reach 642 million in the next 25 years. Till now no medication has been found that can completely cure diabetes. It can only be…
